MIDLAND, ON – LabX Media Group (LMG), parent company to LabX.com, Lab Manager and The Scientist, announced today that it has finalized the acquisition of Biotech Connect Inc. (BTC), a leading provider of onsite vendor shows of scientific products.

LabX Media Group is proud to announce the addition of BTC to our portfolio. BTC’s mission is to connect scientific researchers and life science vendors by bringing them together at live on-campus events, where research scientists can meet with vendors to learn about the latest developments in laboratory products and equipment.

BTC will complement LMG’s existing media products by providing closer relationships between LMG’s audience members and the laboratory product companies that serve them. Guillaume Goyette and Saad Addou launched BTC in 2014. Over the past year, BTC managed over 90 shows and plans to produce close to 150 events in 2016.

“It is very exciting to be working with the high energy and experience of Saad and Guillaume,” said Bob Kafato, president of LMG. “Our acquisition of BTC complements our overall offerings so we can now provide multiple media platforms to the research marketplace. This investment represents an important strategic opportunity to connect attendees of BTC events with the audience of The Scientist, Lab Manager and LabX.com, and LMG will be able to help BTC achieve higher attendee numbers and attract more vendors.”

“From our perspective,” said Dr. Goyette, “there is a natural fit between the activities of BTC and the strategic positioning of LMG as a media company for the laboratory professional. Our capability and know-how in the event organization sector will greatly synergize with the cross-platform publishing expertise of LMG.” According to Mr. Addou, “joining LMG will definitely help us establish a strong foothold in Canada and the US and, at the same time, will enable our customers to benefit from a more diversified portfolio of products and services. We are excited to be part of LMG and eager to contribute to its advancement and that of the life science industry.”